Silvie Huijben

Add links
From Wikipedia, the free encyclopedia
Silvie Huijben
Alma materWageningen University and Research
University of Edinburgh
Known forAntimalarial resistance and insecticide resistance
Scientific career
FieldsEvolutionary biologist, disease ecologist, malariologist
InstitutionsArizona State University
Pennsylvania State University
Barcelona Biomedical Research Park (ISGlobal)

Silvie Huijben is an evolutionary biologist and assistant professor at Arizona State University.[1][2] The Huijben Lab uses fieldwork, lab experiments, and mathematical modeling to study antimalarial and insecticide resistance in parasites, such as disease-transmitting mosquitoes.[2][3][4][5] Her work is focused on applying evolutionary theory to produce resistance management strategies to best combat malaria.[6][7][8]

Education[edit]

Huijben received a PhD in cell, animal and population biology from the University of Edinburgh, UK (October 2006 to January 2010).[1] She received a MSc in biology from Wageningen University, Netherlands (June 2003 to August 2006) and a BSc in biology (September 2000 to November 2004).[1]

Career[edit]

After completing her PhD in 2010, Huijben worked as a post-doctoral scholar at the Center for Infectious Disease Dynamics (CIDD), Pennsylvania State University, USA where she used a rodent malaria model to study the evolution of drug resistance.[1][9][10] In November 2013 she began work as a post-doctoral fellow at Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.[1] In June 2017 she became an Assistant Research Professor at ISGlobal before moving on to an assistant professor role at the Center for Evolution and Medicine, Arizona State University, USA in March 2018.[1]

She has been an editorial board member of PLOS ONE since July 2018.

Public engagement and media[edit]

Huijben has appeared on 2Scientists,[11] was a panelist on a Virtual Keystone Symposia,[12] and was featured on MESA presenting her research for the 67th ASTMH annual meeting.[13]

Research[edit]

The Huijben Lab focuses on the key question: how can we use evolutionary theory to better design resistance management strategies?.[2][1] The lab's current research projects are centered around:[2][6][3][7][14]

  1. understanding the relation between insecticide resistance and malaria epidemiology
  2. determining optimal insecticide resistance management strategies
  3. determining optimal antimalarial resistance management strategies
  4. understanding insecticide resistance patterns in the field

Awards and recognition[edit]

In 2013, she was a recipient of the Marie Curie International Incoming Fellowship,[15] and the Society in Science – Branco Weiss Fellowship[16] to pursue her research in the evolution of drug and insecticide resistance.

In 2020, Dr. Huijben earned the Centennial Professorship Award [17] at Arizona State University for her unique dedication to biological pedagogy.[18]

References[edit]

  1. ^ a b c d e f g "Silvie Huijben | School of Life Sciences". sols.asu.edu. Retrieved 2019-05-04.
  2. ^ a b c d "The Huijben Lab – Center for Evolution and Medicine – Arizona State University". www.huijbenlab.net. Retrieved 2019-05-04.
  3. ^ a b Huijben, Silvie; Paaijmans, Krijn P. (2018). "Putting evolution in elimination: Winning our ongoing battle with evolving malaria mosquitoes and parasites". Evolutionary Applications. 11 (4): 415–430. doi:10.1111/eva.12530. PMC 5891050. PMID 29636796.
  4. ^ Read, Andrew F.; Day, Troy; Huijben, Silvie (28 June 2011). "The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy". Proceedings of the National Academy of Sciences of the United States of America. 108 (Suppl 2): 10871–10877. Bibcode:2011PNAS..10810871R. doi:10.1073/pnas.1100299108. PMC 3131826. PMID 21690376.
  5. ^ "Silvie Huijben – Grants — Arizona State University". asu.pure.elsevier.com.
  6. ^ a b Resistance, The malERA Refresh Consultative Panel on Insecticide and Drug (30 November 2017). "malERA: An updated research agenda for insecticide and drug resistance in malaria elimination and eradication". PLOS Medicine. 14 (11): e1002450. doi:10.1371/journal.pmed.1002450. PMC 5708661. PMID 29190671.
  7. ^ a b "Scopus preview - Scopus - Author details (Huijben, Silvie)". www.scopus.com.
  8. ^ Huijben, Silvie; Bell, Andrew S.; Sim, Derek G.; Tomasello, Danielle; Mideo, Nicole; Day, Troy; Read, Andrew F. (2013). "Aggressive Chemotherapy and the Selection of Drug Resistant Pathogens". PLOS Pathogens. 9 (9): e1003578. doi:10.1371/journal.ppat.1003578. PMC 3771897. PMID 24068922.
  9. ^ "public health - New research findings from Princeton University". blogs.princeton.edu. 6 April 2016.
  10. ^ Huijben, Silvie; Chan, Brian H K.; Nelson, William A.; Read, Andrew F. (2018). "The impact of within-host ecology on the fitness of a drug-resistant parasite". Evolution, Medicine, and Public Health. 2018 (1): 127–137. doi:10.1093/emph/eoy016. PMC 6061792. PMID 30087774.
  11. ^ FM, Player (31 January 2016). "Making It Hard To Resist 2Scientists podcast". player.fm. Retrieved 2019-05-04.
  12. ^ Malaria: From Innovation to Eradication, retrieved 2019-05-04
  13. ^ "ASTMH 2018, Silvie Huijben: "Putting evolution in elimination: winning our ongoing battle with evolving malaria mosquitoes and parasites" | Mesa". mesamalaria.org. Retrieved 2019-05-04.
  14. ^ Lambert, Jonathan (16 January 2019). "Bacteria In Worms Make A Mosquito Repellent That Might Beat DEET". NPR.org.
  15. ^ "Silvie Huijben receives Marie Skłodowska-Curie fellowship". The Branco Weiss Fellowship - Society in Science.
  16. ^ "Alumni Profiles". The Branco Weiss Fellowship - Society in Science.
  17. ^ "Centennial Professorship Award". Arizona State University.
  18. ^ "ASU Professor Wins Centennial Professorship Award". ASU Now: Access, Excellence, Impact. 7 April 2020.

External links[edit]

Retrieved from "https://en.wikipedia.org/w/index.php?title=Silvie_Huijben&oldid=1217692343"